Clinical Trials Browser

Observational × donafenib × Gastrointestinal × Clear all

NCT07180459 2025-09-18

The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational Study

Not yet recruiting

Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular

NCT05713994 2025-03-25

CCGLC-001

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05205629 2022-03-23

A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC

Gastrointestinal

Carcinoma, Hepatocellular